Green Cross Health Ltd · NZX:GXH

Green Cross Health — FY2023 Earnings Presentation

27 slides from Green Cross Health's earnings presentation, May 30, 2023

  1. Slide 1: Green Cross Health Annual Results

    GREEN CROSS HEALTH Annual Results for the Unichem? Life-© @pinrop GREEN - thedoctors House HEALTH

  2. Slide 2: Disclaimer

    Disclaimer The information in this presentation was prepared by Green Cross Health Limited (GXH) with due care and attention. However, the information is supplied in summary form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness or reliability

  3. Slide 3: Operational Highlights

    Operational Highlights • $15.5m increase in Group Revenue year-on-year Group • 89% increase in reported Net Profit After Tax attributable to shareholders1 • Divestment of Community Health division on 28 February Highlights 2023, gain of $21.8m • GXH recognised as a Top 10 most desirable place to wor

  4. Slide 4: Community Health Division Divested

    Community Health Division Divested • In February 2023, Access Community Health and Total Care Health were divested to Anchorage Capital Partners • The sale valued the Community Health Division at an enterprise value of $50.0m • Gain on sale of $21.8m • Net cash sale proceeds supported the payment of

  5. Slide 5: GXH Annual Result - Financial Overview

    GXH Annual Result - Financial Overview Group Performance Divisional Performance Group Revenue (continuing operations) Pharmacy Operating Profit $493.6m $21.1m 3% increase vs FY22 41% decrease vs FY22 Operating Profit/EBIT (continuing operations) Medical Operating Profit $34.3m $16.2m 29% decrease vs

  6. Slide 6: Pharmacy Division

    Pharmacy Division New Zealand’s largest network of health retailers: supporting easy access to quality health care

  7. Slide 7: Pharmacy Performance

    Pharmacy Performance Pharmacy Operating Revenue ($m) 367.1 360.4 • Revenue of $360.4m 336.4 316.8 • Operating Profit at $21.1m FY20 FY21 FY22 FY23 • Following record profit in FY22 driven by COVID-19 vaccination activity, Pharmacy Operating Profit ($m) Operating Profit down 41% with shift in revenue

  8. Slide 8: Record Year For Flu Vaccinations

    Record Year For Flu Vaccinations 300 285 250 200 175 Thousands 148 150 140 114 100 91 91 74 50 110 49 57 40 0 FY20 FY21 FY22 FY23 GXH Equity pharmacies GXH Licensee pharmacies • COVID-19 vaccination resource diverted to focus on flu vaccinations, with volumes up 93% year on year GXH Annual Results P

  9. Slide 9: Living Rewards Members Spend 65% More Than Non-members

    Living Rewards Members Spend 65% More Than Non-members Continued Growth in Living Rewards Members 1,952,661 Living 2.00 1.95 Rewards Members 1.90 Million members 1.85 ✓ 3.5% growth in Living Rewards members to 1.95m 1.80 1.75 ✓ Successful new member acquisition campaigns 1.70 1.65 added 66,583 new m

  10. Slide 10: Differentiated Products Increased to 23% of Retail Sales

    Differentiated Products Increased to 23% of Retail Sales Growth in Differentiated Brand Sales Average E-commerce Order Value Lifted 25% $100 Average order value % of Retail sales 7% 6% 20% $80 Average order value % of retail sales 5% % of retail sales 15% $60 4% 10% $40 3% 2% 5% $20 1% 0% $0 0% FY20

  11. Slide 11: Investment in Technology and People

    Investment in Technology and People Technology • Digital capability enhanced through partnership with technology company MedAdvisor • 223 stores now using SMS alerts, reaching almost 500,000 customers • Unichem and Life Pharmacy branded app to support omni-channel customer interaction built and laun

  12. Slide 12: Largest National Pharmacy Network

    Largest National Pharmacy Network 285 ✓ New Zealand’s largest network of health retailers with 342 stores nationwide ✓ Dispensed over 34 million scripts, representing ~40% of all New Zealand volumes 57 ✓ Year-on-year growth in GXH equity store script volumes, with initial script volumes up 11% and t

  13. Slide 13: Pharmacy Will Win By Focusing on the Customer

    Pharmacy Will Win By Focusing on the Customer Workforce productivity Differentiated brand and & occupancy cost products, recognising control Brand & customer loyalty Cost focus customer Leveraging our trusted Professional instore brands, advocating for equity Network scale & Retail experience, margi

  14. Slide 14: Medical Division

    Medical Division Growth, leadership and sustainable models of care

  15. Slide 15: Medical Performance

    Medical Performance Medical Operating Revenue ($m) 133.2 111.0 Revenue up 20% to $133.2m, driven 76.5 82.2 by COVID-19 activity in the first half of the year, along with acquisitions Operating Profit up 1% to $16.2m, FY20 FY21 FY22 FY23 with labour cost pressures and reduced COVID-19 swabbing Medica

  16. Slide 16: Acquiring and Integrating New Centres

    Acquiring and Integrating New Centres ✓ Another year of accelerated Medical Acquisitions acquisition activity with eight centres acquired in year, to close 9 8 with 61 medical centres ✓ Two more acquisitions completed post year-end 3 1 ✓ Strong pipeline of future FY20 FY21 FY22 FY23 acquisitions ✓ T

  17. Slide 17: Growing The Doctors Brand

    Growing The Doctors Brand The Doctors rebrand programme continues with five centres completed in year Upgrades to modernise three medical centres, improving operational efficiencies and enhancing the patient experience Refurbishments 3 3 1 0 FY20 FY21 FY22 FY23 GXH Annual Results Presentation 30 May

  18. Slide 18: Operational Improvement Initiatives Continue

    Operational Improvement Initiatives Continue Double Digit EBIT Margin Through Operational Efficiency and Cost Management 80% 16% ✓ Following record-high COVID-19 earnings in 70% 14% FY22, EBIT margin came in at 12% for 60% 12% FY23, despite inflationary labour pressures ✓ Other costs reduced to ~17%

  19. Slide 19: Focus on Technology

    Focus on Technology Further investment in newly created Virtual Care Team and expansion of HouseCall digital consultation capability No. of SMS texts No. of website sent 3,072,671 hits 520,038 Page views Patient emails sent via 1,300,206 Chatterbox 411,466 GXH Annual Results Presentation 30 May 2023

  20. Slide 20: Medical Strategy of Organic Growth & Acquisitions

    Medical Strategy of Organic Growth & Acquisitions Workforce productivity High quality patient care & margin management Cost & margin Patient & focus Brand Continuous improvement Targeted centre focus, clinical development acquisitions Operational Scale improvement Technology Utilising data and syste

  21. Slide 21: Group Financial Result

    Group Financial Result 12 months ending 31 March 2023 GXH Annual Results Presentation 30 May 2023 Pg 21

  22. Slide 22: Group Revenue and Operating Profit

    Group Revenue and Operating Profit GXH Operating Revenue From Continuing Operations GXH Operating Profit From Continuing Operations ($m) ($m) 48.5 478 494 34.3 413 399 29.8 31.4 FY20 FY21 FY22 FY23 FY20 FY21 FY22 FY23 • Revenue of $494m, up 3% • Operating Profit from continuing operations of • FY23

  23. Slide 23: Group NPAT, EPS & Dividend

    Group NPAT, EPS & Dividend GXH Net Profit After Tax Attributable to Shareholders Dividends Per Share ($m) (cps) 45.2 6.5 7.0 23.9 16.8 3.5 13.5 0.0 FY20 FY21 FY22 FY23 FY20 FY21 FY22 FY23 Based on dividends declared during the financial year GXH Net Profit After Tax Attributable to Shareholders (cps

  24. Slide 24: Working Capital Management Disciplines Supporting Further Acquisition Activity

    Working Capital Management Disciplines Supporting Further Acquisition Activity Gearing Ratio (debt / debt + equity attributable to GXH Operating Cash Flow ($m) shareholders) 29.5% 70.9 65.8 54.3 45.9 14.0% 13.3% 11.0% FY20 FY21 FY22 FY23 FY20 FY21 FY22 FY23 • Gearing ratio of 11.0% in FY23 • Operati

  25. Slide 25: About Green Cross Health

    About Green Cross Health GXH Annual Results Presentation 25 May 27 June2022 2020 Pg 25Pg 25

  26. Slide 26: Our Purpose

    Our Purpose Working together to support healthier communities. We are passionately committed to the health and wellness of New Zealand, and to providing the best support, care and advice to our communities. This is our promise. GXH Annual Results Presentation 25 May 27 June2022 2020 Pg 26Pg 26

  27. Slide 27: Who We Are

    Who We Are Pharmacies providing extensive range of health, wellness and beauty related products and services across communities throughout New Zealand, supported by digital offerings General practice networks across New Zealand, offering in-practice and virtual services GXHAs at May Annual 2023 Pres

Green Cross Health — FY2023 Earnings Presentation on 6ix